260 related articles for article (PubMed ID: 11350868)
1. Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.
Ramsay D; Bevan N; Rees S; Milligan G
Br J Pharmacol; 2001 May; 133(2):315-23. PubMed ID: 11350868
[TBL] [Abstract][Full Text] [Related]
2. Inverse agonist-induced up-regulation of the human beta2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells.
MacEwan DJ; Milligan G
Mol Pharmacol; 1996 Dec; 50(6):1479-86. PubMed ID: 8967968
[TBL] [Abstract][Full Text] [Related]
3. Ligand specific up-regulation of a Renilla reniformis luciferase-tagged, structurally unstable muscarinic M3 chimeric G protein-coupled receptor.
Zeng FY; McLean AJ; Milligan G; Lerner M; Chalmers DT; Behan DP
Mol Pharmacol; 2003 Dec; 64(6):1474-84. PubMed ID: 14645678
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of inverse agonists in cells overexpressing a constitutively active beta2-adrenoceptor and type II adenylyl cyclase.
Stevens PA; Milligan G
Br J Pharmacol; 1998 Jan; 123(2):335-43. PubMed ID: 9489623
[TBL] [Abstract][Full Text] [Related]
5. Development of a dual glow-signal firefly and Renilla luciferase assay reagent for the analysis of G-protein coupled receptor signalling.
Stables J; Scott S; Brown S; Roelant C; Burns D; Lee MG; Rees S
J Recept Signal Transduct Res; 1999; 19(1-4):395-410. PubMed ID: 10071773
[TBL] [Abstract][Full Text] [Related]
6. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
7. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
8. RGS2 interacts with Gs and adenylyl cyclase in living cells.
Roy AA; Baragli A; Bernstein LS; Hepler JR; Hébert TE; Chidiac P
Cell Signal; 2006 Mar; 18(3):336-48. PubMed ID: 16095880
[TBL] [Abstract][Full Text] [Related]
9. Measurement of agonist-dependent and -independent signal initiation of alpha(1b)-adrenoceptor mutants by direct analysis of guanine nucleotide exchange on the G protein galpha(11).
Carrillo JJ; Stevens PA; Milligan G
J Pharmacol Exp Ther; 2002 Sep; 302(3):1080-8. PubMed ID: 12183666
[TBL] [Abstract][Full Text] [Related]
10. Visualizing differences in ligand regulation of wild-type and constitutively active mutant beta(2)-adrenoceptor-green fluorescent protein fusion proteins.
McLean AJ; Bevan N; Rees S; Milligan G
Mol Pharmacol; 1999 Dec; 56(6):1182-91. PubMed ID: 10570045
[TBL] [Abstract][Full Text] [Related]
11. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
Yu YA; Szalay AA
Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ligand-induced conformational states in the beta 2 adrenergic receptor.
Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P
J Recept Signal Transduct Res; 1999; 19(1-4):293-300. PubMed ID: 10071765
[TBL] [Abstract][Full Text] [Related]
13. Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors.
McLean AJ; Milligan G
Br J Pharmacol; 2000 Aug; 130(8):1825-32. PubMed ID: 10952671
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Gehlert DR; Schober DA; Morin M; Berglund MM
Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
[TBL] [Abstract][Full Text] [Related]
15. Method for identifying ligands activating either excitatory or inhibitory G-protein-coupled receptors by functional coexpression in Xenopus oocytes.
Owman C; Mahan LC
Biochem Biophys Res Commun; 1997 Apr; 233(3):853-6. PubMed ID: 9168947
[TBL] [Abstract][Full Text] [Related]
16. Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.
Pauwels PJ; Tardif S
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):134-41. PubMed ID: 12122500
[TBL] [Abstract][Full Text] [Related]
17. Use of constitutive G protein-coupled receptor activity for drug discovery.
Chen G; Way J; Armour S; Watson C; Queen K; Jayawickreme CK; Chen WJ; Kenakin T
Mol Pharmacol; 2000 Jan; 57(1):125-34. PubMed ID: 10617687
[TBL] [Abstract][Full Text] [Related]
18. Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor.
Ding Z; Kim S; Kunapuli SP
Mol Pharmacol; 2006 Jan; 69(1):338-45. PubMed ID: 16234484
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the activation state of insulin/insulin-like growth factor-1 hybrid receptors using bioluminescence resonance energy transfer.
Blanquart C; Gonzalez-Yanes C; Issad T
Mol Pharmacol; 2006 Nov; 70(5):1802-11. PubMed ID: 16926280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
